SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-069279
Filing Date
2024-06-05
Accepted
2024-06-05 16:05:03
Documents
2
Period of Report
2024-05-28

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 8034
2 EX-24 glue-ex24.htm EX-24 10794
  Complete submission text file 0000950170-24-069279.txt   20303
Mailing Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118
Business Address 321 HARRISON AVENUE SUITE 900 BOSTON MA 02118 617-949-2643
Monte Rosa Therapeutics, Inc. (Issuer) CIK: 0001826457 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address MONTE ROSA THERAPEUTICS, INC. 40 GUEST STREET BOSTON MA 02135
Business Address
Townson Sharon (Reporting) CIK: 0001855689 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40522 | Film No.: 241021962